Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis

NCT02487407 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: ODM-109
DRUG: Placebo for ODM-109

Sponsor

Orion Corporation, Orion Pharma